首页> 外文期刊>American Journal of Physiology >Surfactant protein B inhibits secretory phospho-lipase A_2 hydrolysis of surfactant phospholipids.
【24h】

Surfactant protein B inhibits secretory phospho-lipase A_2 hydrolysis of surfactant phospholipids.

机译:表面活性剂蛋白B抑制表面活性剂磷脂的分泌性磷脂酶A_2水解。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Hydrolysis of surfactant phospholipids (PL) by secretory phospholipases A_2 (sPLA_2) contributes to surfactant damage in inflammatory airway diseases such as acute lung injury/acute respiratory distress syndrome. We and others have reported that each sPLA_2 exhibits specificity in hydrolyzing different PLs in pulmonary surfactant and that the presence of hydro-philic surfactant protein A (SP-A) alters sPLA_2-mediated hydrolysis. This report tests the hypothesis that hydrophobic SP-B also inhibits sPLA_2-mediated surfactant hydrolysis. Three surfactant preparations were used containing varied amounts of SP-B and radiolabeled tracers of phosphatidylcholine (PC) or phosphatidylglycerol (PG): 1) washed ovine surfactant (OS) (pre- and postorganic extraction) compared with Survanta (protein poor), 2) Survanta supplemented with purified bovine SP-B (1-5%, wt/wt), and 3) a mixture of dipalmitoylphos-phatidylcholine (DPPC), 1 -palmitoyl-2-oleoyl-phosphatidylcholine (POPC), and l-palmitoyl-2-oleoyl-phosphatidylglycerol (POPG) (DPPQPOPGPOPG, 40:40:20) prepared as vesicles and monomo-lecular films in the presence or absence of SP-B. Hydrolysis of PG and PC by Group IB sPLA_2 (PLA2G1A) was significantly lower in the extracted OS, which contains SP-B, compared with Survanta (P = 0.005), which is SP-B poor. Hydrolysis of PG and PC in nonextracted OS, which contains all SPs, was lower than both Survanta and extracted OS. When Survanta was supplemented with 1% SP-B, PG and PC hydrolysis by PLA2G1B was significantly lower (P < 0.001) than in Survanta alone. When supplemented into pure lipid vesicles and monomolecular films composed of PG and PC mixtures, SP-B also inhibited hydrolysis by both PLA2G1B and Group IIA sPLA2 (PLA2G2A). In films, PLA2G1B hydrolyzed surfactant PL monolay-ers at surface pressures approx=30 mN/m (P < 0.01), and SP-B lowered the surface pressure range at which hydrolysis can occur. These results suggest the hydrophobic SP, SP-B, protects alveolar surfactant PL from hydrolysis mediated by multiple sPLA_2 in both vesicles (alveolar subphase) and monomolecular films (air-liquid interface).
机译:分泌性磷脂酶A_2(sPLA_2)水解表面活性剂磷脂(PL)有助于炎症性气道疾病(例如急性肺损伤/急性呼吸窘迫综合征)中的表面活性剂破坏。我们和其他人已报道,每种sPLA_2在水解肺表面活性剂中的不同PL时均表现出特异性,并且亲水性表面活性剂蛋白A(SP-A)的存在会改变sPLA_2介导的水解作用。该报告检验了疏水性SP-B也抑制sPLA_2介导的表面活性剂水解的假设。使用了三种表面活性剂制剂,它们含有不同量的SP-B和放射性标记的磷脂酰胆碱(PC)或磷脂酰甘油(PG)示踪剂:1)与Survanta(蛋白质贫乏)相比,洗过的绵羊表面活性剂(OS)(有机萃取前后),2 )补充有纯牛SP-B(1-5%,wt / wt)的Survanta,和3)二棕榈酰磷酰磷脂酰胆碱(DPPC),1-棕榈酰-2-油酰磷脂酰胆碱(POPC)和1-棕榈酰的混合物在存在或不存在SP-B的情况下,制备为囊泡和单分子膜的-2-油基磷脂酰甘油(POPG)(DPPQPOPGPOPG,40:40:20)。 IB组sPLA_2(PLA2G1A)对含有SP-B的提取OS中PG和PC的水解作用明显低于SP-B较弱的Survanta(P = 0.005)。包含所有SP的非提取OS中PG和PC的水解均低于Survanta和提取OS。当Survanta补充有1%SP-B时,PLA2G1B的PG和PC水解明显低于单独的Survanta(P <0.001)。当补充到由PG和PC混合物组成的纯脂质囊泡和单分子膜中时,SP-B还抑制PLA2G1B和IIA组sPLA2(PLA2G2A)的水解。在薄膜中,PLA2G1B在约30 mN / m的表面压力下水解表面活性剂PL单层膜(P <0.01),而SP-B降低了可发生水解的表面压力范围。这些结果表明,疏水性SP SP-B保护了泡囊表面活性剂PL免受囊泡(肺泡亚相)和单分子膜(气液界面)中多个sPLA_2介导的水解作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号